Evaluation of the mobilization device VEMO as part of the MobIPaR project

Not Applicable

• Conditions: G72.80; G93; G82; Other disorders of brain; S06; Inflammatory polyneuropathy; I60-I69; G62.80; G61; Cerebrovascular diseases

• Registration Number: DRKS00018984
• Lead Sponsor: Schön Klinik Bad Aibling Harthausen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-10-15
• Study Completion: 2021-04-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

• neuro Reha- Phase B and C patients
• Barthel Index <= 35 ~ (severe and very
heavy engine. Impairment)
• Inability to walk (FAC2 <2)
• Age:> 18 years
• Weight:> 45kg, <135kg
• Height:> 1,50m, <1,95m
• Diagnoses: TBI, stroke (ICB or ischemic) or hypoxic brain damage, CIP / CIM, GBS, paraplegia
• Intensive surveillance

DOC (n = 6)
• MCS = minimally conscious state or RW: unresponsiveness, classification based on the CRS-r scale (according to (Giacino et al., 2004)

Non-DOC (n = 6)
• Patients without DOC symptoms (classification also based on the CRS-r scale)
• Orientation to the person and situation
• German Speaking

Exclusion Criteria

• patients in intensive care
• ventilation
• Severe contractures, severe spasticity (MAS1> 3)
• Myocardial infarction <4 weeks before study
• Pacemaker
• severe osteoporosis
• Decubitus or unstable fractures on treatment-relevant areas

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Investigate the safe applicability of VEMO therapy and ease of use (workload and usability) among all individuals involved (patients, therapists, nurses). Establishment of an optimized usage protocol.

Secondary Outcome Measures

Name	Time	Method
Obtaining information for further technical development and optimization of the VEMO (eg autoadaptivity, Assist-as-Needed function) as well as for the derivation of an optimal implementation strategy of the robotic device into the clinical routine.